ORIC Overview
Upcoming Projects (ORIC)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (ORIC)
-
Discussing ORIC Pharmaceuticals's Rinzimetostat (ORIC-944), a PRC2 (EED) Inhibitor in Combination with Darolutamide for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Ticker: ORIC
Executed On: Apr 27, 2026 at 01:00 PM EDT -
A Second Look: Discussing ORIC Pharmaceuticals's Rinzimetostat (ORIC-944), a PRC2 (EED) Inhibitor in Combination with Darolutamide for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Ticker: ORIC
Executed On: Apr 24, 2026 at 02:00 PM EDT -
A Second Look: Discussing the role of the PRC2/EZH2/EED pathway in prostate cancer
Tickers: ORIC, EPIX, PFE
Executed On: Jul 26, 2024 at 12:30 PM EDT -
Discussing the role of the PRC2/EZH2/EED pathway in prostate cancer
Tickers: ORIC, EPIX, PFE
Executed On: Jul 12, 2024 at 10:00 AM EDT
Upcoming & Overdue Catalysts (ORIC)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (ORIC)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
